12:31am Monday 20 November 2017

Research aims to unlock the effects of a childhood condition on the brain

Professor Volker Straub, from the Institute of Genetic Medicine, will conduct a three-year study on how Duchenne muscular dystrophy affects the brain, an aspect of the condition of which little is currently known.

Learning difficulties and cognitive issues are common among the 2,500 children and young people with Duchenne muscular dystrophy, which is caused by the lack of a vital muscle protein and leads to increasingly severe disability.

Following decades of research, several potential treatments are now in clinical trials. By tracking changes in the brain as the condition progresses, Professor Straub hopes to both improve knowledge and to help measure the effectiveness of future treatments.

The research is being funded by a £136,000 grant from Muscular Dystrophy UK.

Professor Volker Straub, honorary consultant in clinical genetics at Newcastle Hospitals NHS Foundation Trust, said: “Over the past 25 years most of our research efforts in Duchenne muscular dystrophy have been focussed on trying to better understand the mechanisms that are leading to progressive muscle weakness, including the weakness of the respiratory muscles and the heart muscle.

“These were of course, and still are, very important issues that need to be addressed. Nevertheless, we have probably neglected research that investigates the brain function in patients with Duchenne muscular dystrophy.

“Many families point out that learning difficulties and particularly behavioural problems in their sons are as worrying for them as the muscle symptoms. I’m therefore very grateful to Muscular Dystrophy UK that our grant looking at the brain in Duchenne muscular dystrophy, and in some other muscular dystrophies by magnetic resonance imaging, has been successfully funded.”

Scores of families living with Duchenne muscular dystrophy have helped to make the grant possible by supporting Muscular Dystrophy UK’s Duchenne Research Breakthrough Fund. The Fund is on track to raise £2.7 million for cutting-edge treatment research by 2017.

Child sufferer 

George Pegg, 12, from Blyth, Northumberland, has Duchenne muscular dystrophy. His family set up a fund called George’s Journey to back research into the condition.

George’s mum, Lilian, said: “Research like this is so important. George doesn’t have cognitive issues, but we know this is an additional challenge that many children with Duchenne muscular dystrophy face. Being able to fund research to give us more understanding of the condition and what causes some of these issues is a great thing.”

Muscular Dystrophy UK said the research project is a vital step towards further understanding the complex condition.

Dr Marita Pohlschmidt, Muscular Dystrophy UK’s Director of Research, said: “We are proud to be funding Professor Straub’s invaluable study. It is vital that we thoroughly understand its effect on all areas of the body, to develop the most effective treatments possible.

“Many children born with Duchenne muscular dystrophy will live with learning difficulties or impaired cognitive function. Professor Straub’s research will shine a spotlight on the condition’s effect on the brain, vastly improving our knowledge of the processes taking place.”

 

published on: 7th September 2015

Key Facts:

  • Newcastle University is a Russell Group University
  • Ranked in the top 1% of universities in the world (QS World University Rankings 2014)
  • Ranked 16th in the UK for global research power (REF 2014)
  • Ranked 10th overall in the UK and 3rd for quality of staff/lecturers in the Times Higher Education Student Experience Survey 2015
  • Winner: Outstanding Leadership and Management Team and Outstanding Procurement Team, Times Higher Leadership and Management Awards 2015
  • Amongst our peers Newcastle is:
    • Joint 6th in the UK for student satisfaction
    • Ranked 1st in the UK for Computing Science research impact, 3rd in the UK for Civil Engineering research power and 11th in the UK for Mathematical Sciences research (REF 2014)
    • Ranked 8th in the UK for Medical and Life Sciences research quality (REF 2014)
    • Ranked 3rd in the UK for English, and in the top 12 for Geography, Architecture and Planning, and Cultural and Media Studies research quality (REF 2014)
    • Engineering and Physical Sciences Research Council (EPSRC) top 20 strategic partner
  • 94% of our students are in a job or further training within six months of graduating
  • We have a world-class reputation for research excellence and are spearheading three major societal challenges that have a significant impact on global society. These themes are: Ageing, Sustainability, and Social Renewal
  • Newcastle University is the first UK university to establish a fully owned international branch campus for medicine at its NUMed Campus in Malaysia which opened in 2011
  • 90% Satisfaction level from our international students (ISB 2014)
  • Newcastle University Business School is one of 20 Triple Accredited Business Schools in the UK

Share on:
or:

Health news